Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections
A number of national guidelines have been published to aid the antimicrobial management of community-acquired pneumonia. However, data on prescriptions for lower respiratory tract infection (LRTI) indicate considerable variation in the choice of first-line and subsequent therapy at national and loca...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1998-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/1998/527248 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562273824014336 |
|---|---|
| author | Alasdair P MacGowan Tracey Halladay Andrew M Lovering |
| author_facet | Alasdair P MacGowan Tracey Halladay Andrew M Lovering |
| author_sort | Alasdair P MacGowan |
| collection | DOAJ |
| description | A number of national guidelines have been published to aid the antimicrobial management of community-acquired pneumonia. However, data on prescriptions for lower respiratory tract infection (LRTI) indicate considerable variation in the choice of first-line and subsequent therapy at national and local levels. Outcomes research in LRTI, whether based on clinical, economic or patient-focused criteria, is still evolving. Clinical outcomes are best studied for both pneumonia and exacerbation of chronic obstructive pulmonary disease. Economic evaluations often do not encompass all of the costs, for example, time off from work or the economic impact of antibacterial resistance. Duration of hospital stay is a good marker of costs for hospital providers and may be affected by age. marital status and comorbidities. Antibiotic choice may have an impact on the duration of hospital stay by increasing side effects, predisposing patients to hospitalacquired infection or reduced clinical efficacy. Patient expectation is largely unstudied in pulmonary infection. |
| format | Article |
| id | doaj-art-7c7a04be7b5e4c1486f31230cc836082 |
| institution | Kabale University |
| issn | 1180-2332 |
| language | English |
| publishDate | 1998-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases |
| spelling | doaj-art-7c7a04be7b5e4c1486f31230cc8360822025-02-03T01:23:07ZengWileyCanadian Journal of Infectious Diseases1180-23321998-01-019Suppl E30E34E10.1155/1998/527248Current Antibiotic Treatment and Outcome for Lower Respiratory Tract InfectionsAlasdair P MacGowan0Tracey Halladay1Andrew M Lovering2Bristol Centre for Antimicrobial Research & Evaluation, Department ef Medical Microbiology, Southmead Hospital, Westbury-on-Trym, Bristol, UKBristol Centre for Antimicrobial Research & Evaluation, Department ef Medical Microbiology, Southmead Hospital, Westbury-on-Trym, Bristol, UKBristol Centre for Antimicrobial Research & Evaluation, Department ef Medical Microbiology, Southmead Hospital, Westbury-on-Trym, Bristol, UKA number of national guidelines have been published to aid the antimicrobial management of community-acquired pneumonia. However, data on prescriptions for lower respiratory tract infection (LRTI) indicate considerable variation in the choice of first-line and subsequent therapy at national and local levels. Outcomes research in LRTI, whether based on clinical, economic or patient-focused criteria, is still evolving. Clinical outcomes are best studied for both pneumonia and exacerbation of chronic obstructive pulmonary disease. Economic evaluations often do not encompass all of the costs, for example, time off from work or the economic impact of antibacterial resistance. Duration of hospital stay is a good marker of costs for hospital providers and may be affected by age. marital status and comorbidities. Antibiotic choice may have an impact on the duration of hospital stay by increasing side effects, predisposing patients to hospitalacquired infection or reduced clinical efficacy. Patient expectation is largely unstudied in pulmonary infection.http://dx.doi.org/10.1155/1998/527248 |
| spellingShingle | Alasdair P MacGowan Tracey Halladay Andrew M Lovering Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections Canadian Journal of Infectious Diseases |
| title | Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections |
| title_full | Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections |
| title_fullStr | Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections |
| title_full_unstemmed | Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections |
| title_short | Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections |
| title_sort | current antibiotic treatment and outcome for lower respiratory tract infections |
| url | http://dx.doi.org/10.1155/1998/527248 |
| work_keys_str_mv | AT alasdairpmacgowan currentantibiotictreatmentandoutcomeforlowerrespiratorytractinfections AT traceyhalladay currentantibiotictreatmentandoutcomeforlowerrespiratorytractinfections AT andrewmlovering currentantibiotictreatmentandoutcomeforlowerrespiratorytractinfections |